Secondary breast angiosarcoma: Lethal response to anti-angiogenic therapy with paclitaxel chemotherapy. A case report

Anticancer Research

Volumn 26, Issue 6 C, 2006, Pages 4775-4777

  Tomasello, Laura ^a   Gardin, Giovanni ^a   Boccardo, Francesco ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Breast angiosarcoma; Chemotherapy; Paclitaxel

Indexed keywords

LIVER ENZYME; PACLITAXEL; TAMOXIFEN; URIC ACID;

AGED; ANAMNESIS; ANEMIA; ANGIOSARCOMA; ANTIANGIOGENIC ACTIVITY; ARTICLE; BLOOD CLOTTING; BREAST CARCINOMA; BREAST TUMOR; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CAPILLARY PERMEABILITY; CASE REPORT; ENZYME BLOOD LEVEL; FEMALE; HISTOPATHOLOGY; HUMAN; HYPOVOLEMIA; KIDNEY FAILURE; PRIORITY JOURNAL; SHOCK; SIDE EFFECT; TREATMENT RESPONSE; TUMOR BLEEDING; URIC ACID BLOOD LEVEL;

AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HEMANGIOSARCOMA; HUMANS; NEOPLASMS, SECOND PRIMARY; PACLITAXEL;

EID: 33845949059     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Adem C, Reynolds C, Ingle JN and Nascimento AG: Primary breast sarcoma: clinicopathologic series from the Mayo Clinic and rewiew of the literature. Br J Cancer 91: 237-241, 2004.
2. Del Mastro L, Garrone O, Guenzi M, Cafiero F, Nicole G, Rosso R and Venturini M: Angiosarcoma of the residual breast after conservative surgery and radiotherapy for primary carcinoma. Ann Oncol 5: 163-165, 1994.
3. Fata F, O'Reilly E, Ilson D, Pfister D, Leffel D, Kelsen DP, Schwartz GK and Casper ES: Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer 86: 2034-2037, 1999.
4. Dhillon T, Stebbing J and and Bower M: Paclitaxel for AIDS-associated Kaposi's sarcoma. Expert Rev Anticancer Ther 5: 215-219, 2005.
5. Grant DS, Williams TL, Zahaczewsky M and Dicker AP: Comparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere). Int J. Cancer 104: 121-129, 2003.
6. Lau DH, Xue L, Young LJ and Cheung AT: Paclitaxel (Taxol): an inhibitor of angiogenesis in a higly vascularized transgenic breast cancer. Cancer Biother Radiopharm 14: 31-36, 1999.
7. Lau D, Guo L, Gandara D, Young LJ and Xue L: Is inhibition of cancer angiogenesis and growth by paclitaxel schedule dependent? Anticancer Drugs 15: 871-875, 2004.
8. Fujimoto M, Kiyosawa T, Murata S, Matsuo K, Suzuki H, Sone H, Okuda Y, Nakayama Y and Yaoita H: Vascular endothelial growth factor in angiosarcoma. Anticancer Res 18: 3725-3729, 1998.
9. Gordon MS and Cunningham D: Managing patients treated with bevacizumab combination therapy. Oncology 69: 25-33, 2005.